This column provides reports that situate and synthesize current developments, issues, innovative clinical procedures, therapeutic methods, and promising novel methods of delivery in the related fields of palliative care.
Get full access to this article
View all access options for this article.
References
1.
CurrieJ.L., GallS., WeedJ.C.Jr., CreasmanW.T.Intracavitary Corynebacterium parvum for treatment of malignant effusions.Gynecol Oncol1983; 16: 6–14.
2.
FellettiR., RavazzoniC.Intrapleural Corynebacterium parvum for malignant pleural effusions.Thorax1983; 38: 22–24.
3.
FrayA., MoreauC., ThobieN., DucluzeauR.Propriétés antitumorales cytostatiques et cytotoxiques des cellules péritonéales de souris conventionnelles et axéniques stimulées ou non par Corynebacterium parvum.Ann Inst Pasteur Immunol1981; 132(D): 33–43.
4.
McLeodD.T., CalverleyP.M.A., MillarJ.W., HorneN.W.Further experience of Corynebacterium parvum in malignant pleural effusion.Thorax1985; 40: 515–18.
5.
MantovaniA., SessaC., PeriG., AllavenaP., IntronaM., PolentaruttiN., MangioniC.Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor-associated macrophages and NK cells.Int J Cancer1981; 27: 437–46.
6.
ScottM.T.Corynebacterium parvum as an immuhotherapeutic anticancer agent.Semin Oncol1974; 1: 367–78.
7.
TodoructiuC., MuleaR., DaicoviciuD., RicscaR.In vitro cytochemichal and cytophysiological study of in vivo activated mouse peritoneal macrophages.Morphol Embryol (Bucur)1981; 27: 265–69.
8.
TwycrossR.G., LackS.A.Control of alimentary symptoms it far advanced cancer.Edinburgh, London: Churchill Livingstone, 1986, 282–99.
9.
WebbH.E., OatenS.W., PikeC.P.Treatment of malignant ascitic and pleural effusions with Corynebacterium parvum.Br Med J1978; 1: 338–40.
